Drug Type Synthetic peptide |
Synonyms Omiganan pentachloride, Omiganan pentahydrochloride, Omiganan pentahydrochloride (USAN) + [7] |
Target- |
Action enhancers |
Mechanism Cell membrane permeability enhancers |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Molecular FormulaC90H128ClN27O12 |
InChIKeyXZVPZZJCWDNELR-NLRWEPRHSA-N |
CAS Registry269062-93-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rosacea | Phase 3 | Australia | 13 Aug 2015 | |
Bacteremia | Phase 3 | United States | 01 Sep 2000 | |
Fungemia | Phase 3 | United States | 01 Sep 2000 | |
Dermatitis, Atopic | Phase 2 | Netherlands | 25 Nov 2016 | |
Condylomata Acuminata | Phase 2 | Netherlands | 06 Apr 2016 | |
Vulvar intraepithelial neoplasia | Phase 2 | Netherlands | 21 Nov 2015 | |
Acne Vulgaris | Phase 2 | - | 01 Oct 2000 | |
Propionibacterium Acnes Infection | Phase 2 | - | 01 Oct 2000 | |
Bullous keratopathy | Phase 2 | Japan | - | - |
Phase 3 | 263 | (Treatment) | jnguyivrbv(dkqzunobne) = xsopyvhdci pwtbidjhkt (memoomhqxi, 2.29) View more | - | 08 Jul 2022 | ||
Vehicle (Vehicle Gel) | jnguyivrbv(dkqzunobne) = nnskmdtvdk pwtbidjhkt (memoomhqxi, 2.36) View more | ||||||
Phase 3 | 307 | dtfsfxfbde = lhfburrtcs nigtyxxpsu (yabratezmm, zxhzxyqajl - vkhgvlhxxj) View more | - | 06 Jul 2022 | |||
Phase 2 | 36 | sgmtsknecn(bywimbvspw) = xdbobzxhmg cdijtdtjec (jpfftwpfff, -99.9 to -7.4) | Positive | 01 Nov 2020 | |||
Placebo | - | ||||||
Phase 3 | 30 | (Omiganan 1% Gel (Part 2)) | gespgbviqo(ymftfatwdz) = blnesjkqxe ysilgeetge (ftwmtyuanx, 1.563) View more | - | 25 Jan 2010 | ||
(Chlorhexidine 2%(Part 1)) | gespgbviqo(ymftfatwdz) = uopbfnpvmz ysilgeetge (ftwmtyuanx, 1.656) |